Brind.
  1. Domination in medical technology industry involving Intuitive Surgical, Johnson & Johnson, and Stryker.
  2. Intuitive Surgical and Johnson & Johnson are competing in the robotic surgery market, with J&J maintaining a global office in Santa Clara.

JNJ secured marketing authorization from the U.S. FDA, and its Ottava platform challenges ISRG's market dominance.

7 reports, 2 independent Updated Aug 28
Gone quiet Reached 2 outlets in its first 24 hours
Reports
7
Developments
2
Repetition
71%

New informationRepeats or wire copies

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 2 outlets

JNJ secured marketing authorization from the U.S. FDA, and its Ottava platform challenges ISRG's market dominance.

Who's involved

What this event is mainly about
Johnson & JohnsonIntuitive Surgical

How it developed

Newest first. Tap a step to see who reported it.
  1. FDA authorized Ottava on August 28th, while a related legal verdict took place in Massachusetts.1 source
  2. JNJ secured FDA approval for its Ottava platform, challenging ISRG's market dominance.1 source

Keep exploring

Part of

Intuitive Surgical and Johnson & Johnson are competing in the robotic surgery market, with J&J maintaining a global office in Santa Clara. All 1 developments

Within Domination in medical technology industry involving Intuitive Surgical, Johnson & Johnson, and Stryker.

The entities involved

Related events

Coverage

Newest first; wire copies grouped
3 more outlets ran the same wire story